NCT04749160View on ClinicalTrials.gov

Smart Marker Annunciating Response to Rheumatologic Treatments SMART²T

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

June 4, 2021

Primary Completion Date

February 20, 2022

Study Completion Date

February 20, 2022

Conditions
Rheumatoid Arthritis
Interventions
DEVICE

Connected device

Connected device is a smart watch (with accelerometer without location data).

Trial Locations (13)

25000

Centre Hospitalier de Besancon, Besançon

34000

CHU Montpellier, Montpellier

42055

CHU Saint-Etienne, Saint-Etienne

45100

Centre Hospitalier D'Orleans, Orléans

63000

Centre Hospitalier Universitaire de Clermont Ferrand, Clermont-Ferrand

Unknown

Hôpital Pellegrin, Bordeaux

Clinique de l'Infirmerie Protestante deLyon, Caluire-et-Cuire

Hôpital Sud, Grenoble

CH Le Mans, Le Mans

Hôpital Pitié Salpétrière, Paris

CHU de Reims - Hôpital Maison Blanche, Reims

Hôpital Hautepierre, Strasbourg

Hôpital Pierre-Paul Riquet, Toulouse

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER